The Paradigm system consists of two basic parts: an insulin pump and an optional glucose sensor CGM worn for up to 3 days. Continuous treatment reduces glucose variability. This type of continuous treatment is in contrast to traditional multiple daily injections (MDI) that use slower-acting insulin. In Bolus mode, the delivery is programmed to be a one-time delivery prior to eating or after an unexpected high, for example 18 units spread out to several hours. Basal rates are set to meet individual metabolic rates. In Basal rate mode, the delivery is continuous in small doses similar to a pancreas, for example 0.15 units per hour throughout the day. There is a quick-disconnect feature for the tubing. The infusion set can remain in the place for three days while the pump is clip-belt worn. This "infusion set" is patient-connected via a catheter to the abdomen region. The Minimed Paradigm REAL-Time and Continuous Glucose Monitoring (CGM) system, which received FDA clearance in 2006, uses tubing and a reservoir with rapid-acting insulin. Insulin pumps are drug delivery devices used to treat patients with type 1 and type 2 diabetes.
0 Comments
Leave a Reply. |